학술논문

25(OH)D levels are decreased in patients with difficult-to-treat depression
Document Type
article
Source
Comprehensive Psychoneuroendocrinology, Vol 10, Iss , Pp 100126- (2022)
Subject
MDD
Vitamin D
25(OH)D
Suicidal ideation
Depressive symptoms
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Psychology
BF1-990
Language
English
ISSN
2666-4976
Abstract
Objectives: The aims of the study are i) to compare 25-hydroxyvitamin D (25(OH)D) levels between clinically depressed individuals with insufficient treatment response and healthy controls and ii) to test the association between 25(OH)D levels and different affective disorder diagnoses (i.e., major depressive disorder (MDD) single episode, MDD recurrent episode, chronic MDD, and dysthymia), as well as grade of suicidal ideation. Method: We quantified serum 25(OH)D in 202 individuals with difficult-to-treat depression (DTD) and 41 healthy controls. Patients were diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV-TR). ANCOVA was used to test differences in mean 25(OH)levels between depressed and controls, adjusting for sex, age, smoking, sampling season, ethnicity, somatic illness, and body mass index (BMI). Binary logistic regression models were used to test the association between depression and 25(OH)D levels. Results: Patients with difficult-to-treat depression had significantly lower levels of 25(OH)D compared to healthy controls (ANCOVA, F = 4.89; p = 0.03). Thirty percent of the depressed patients were 25(OH)D deficient (